bpc-157 ulcerative colitis phase ii Frontiers JPP No 5/2013 article 09
Description
The third objective is to elucidate the molecular mechanisms underlying the actions of kisspeptin-10
GIPR = insulin sensitivity / metabolic efficiency
The chronic inflammation cycle has been broken
[DOI] [PubMed] [Google Scholar] 22.Kang E.A., Han Y.M., An J.M., Park Y.J., Sikiric P., Kim D.H., Kwon K.A., Kim Y.J., Yang D., Tchah H., et al
